Health

Why is LivLong365 Betting on Full Stack Healthcare, From Insurance to Care Delivery?
Why is LivLong365 Betting on Full Stack Healthcare, From Insurance to Care Delivery?

Thane (Maharashtra) [India], July 20: India’s healthcare system has been a fragmented, ad-hoc system for decades. A patient buys health insurance from one company, gets their blood test done at another lab that has no connection with the policy, consults with a doctor who has their reports at a completely different place, and then follows up with a third party for their chronic medications.

This results in:

  • Indian families continue to incur huge out-of-pocket expenses
  • The largest portion of that spend is on routine outpatient needs like lab tests, doctor consultations, and medicines
  • Health insurance only covered inpatient hospitalization to date, with no real attention paid to outpatient health expenses, which typically represent a larger portion of the annual family health spend
  • Government-led initiatives like Ayushman Bharat Digital Mission have also increased the focus towards connected, data-driven health records, which further highlight the gap between insurance cover and actual patient needs

What has been missing in the ecosystem till date is the system that didn’t just protect people financially after they fell ill, but helped them manage health proactively, before a hospital visit was ever required.

Why Insurance Alone Is Not Enough

Insurance is inherently reactive. It comes into play only during a medical emergency or acute crisis. But healthcare needs don’t work that way.

People need doctor consultations for basic issues, regular diagnostic check-ups, and ongoing management of chronic ailments. Traditional insurance covers neither outpatient procedures nor chronic care management, leaving patients to bear these costs on their own, while insurance stays limited to major illness and hospitalisation.

This is the gap LivLong 365 set out to close, drawing on IIFL Insurance’s background in healthcare financing. As a long-time health insurance claims processor, LivLong 365 noticed that a large share of a family’s healthcare spend went toward outpatient care, an area no existing insurance product covered.

This insight pushed LivLong 365 beyond insurance distribution into Preventive and Primary healthcare services, including:

  • Online and in-clinic doctor consultations
  • Laboratory testing and diagnostics
  • Wellness and out-patient health plans
  • Home care services like physiotherapy and nursing

This makes LivLong 365 both an Insurance Distributor and a Care Provider, a model the company calls “Payvidor,” merging Payer and Provider for a seamless, continuous health experience.

The Full Stack Healthcare Model

The full-stack model is important because healthcare is never a one-time transaction. A human body is a complex organism, and its well-being has to be a continuous process. If an individual has an infection, he would need:

  • A doctor to consult.
  • A diagnostic to identify the strain.
  • Medicines for treatment.
  • Follow up to ensure the infection doesn’t recur.

When each of these individual needs is served by a separate, disparate company, it not only creates delays but also leads to a lot of redundancy and increases costs.

The most vital thing is that when a single platform handles multiple elements, it facilitates the continuity of the healthcare journey. When the same platform used for purchasing health cover also guides patients to a qualified doctor, helps book appointments, arranges diagnostic tests, and follows up on their treatment progress, a patient can achieve end-to-end care management.

This continuity matters most in surgical care — a journey through three phases: before, during, and after. Pre-surgery, patients need an expert second opinion and clarity on hospital choice and cost. During surgery, they need seamless hospital coordination and cashless claims support. Post-surgery, recovery depends on timely access to labs, pharmacy, and physiotherapy, often at home. LivLong 365 extends its full-stack model into this journey through LivLong SurgiCare, coordinating surgeon opinions, hospital support, and recovery across specialities from orthopedics and cardiology to oncology and robotic surgeries.

This is a game-changer, particularly for working professionals within the SME sector (a large portion of which do not get comprehensive health cover from their employers), and for senior citizens who often need greater continuity in monitoring and care.

Why Healthcare and Financial Protection Are Converging

As health technologies evolve and preventive and continuous care gains in importance, the distinction between financial protection and physical care delivery is blurring. Health tech platforms and insurers are realising that the two must be combined to offer holistic solutions.

Businesses such as LivLong 365 are responding with integrated offerings that bring together:

  • OPD consults
  • Diagnostic services
  • Medications
  • Chronic disease management
  • Surgical care coordination, from planning through recovery

Integration of services is particularly important for a country like India, which has seen a rise in conditions like diabetes and hypertension, and the surgical needs that can follow. A connected system could help detect a health issue early on, before a routine checkup becomes a hospital admission. Getting treatment sooner often helps in better management, and if surgery does become necessary, the patient isn’t navigating it alone.

The transition by LivLong 365 from being an insurance distributor to being a full-stack healthcare provider, with SurgiCare extending that stack into surgical care, shows this shift in the Indian healthcare sector. Rising out-of-pocket costs and growing prevalence of chronic illness demonstrate that just having financial protection is not enough. The industry is moving toward models that offer strong insurance along with simple, integrated access to care at every stage: before, during, and after treatment. Whatever the execution of this will be. The direction is clear: a more connected and customer-first, futuristic healthcare in India.

Disclaimer: This press release is for general information purposes only and should not be construed as medical, financial, or professional advice.

’70–80% of Medical Issues Don’t Need Hospitalization’ — Ashish Srivastava’s Visionary Day-Care Model
’70–80% of Medical Issues Don’t Need Hospitalization’ — Ashish Srivastava’s Visionary Day-Care Model
AI Progress in Healthcare: How Intelligent Technology Is Transforming Patient Care
AI Progress in Healthcare: How Intelligent Technology Is Transforming Patient Care
You’re Not Deficient. Your Diet Just Has Gaps.
You’re Not Deficient. Your Diet Just Has Gaps.

Business

Advit Jewels Delivers Strong FY26 Growth with 33.68% YoY Rise in Income and 35.56% YoY Increase in Net Profit
Advit Jewels Delivers Strong FY26 Growth with 33.68% YoY Rise in Income and 35.56% YoY Increase in Net Profit

Jaipur (Rajasthan) [India], July 21: Advit Jewels Limited (RAMBHAJO, BSE: 544803), one of India’s leading manufacturers of traditional and contemporary handcrafted jewellery, specializing in Kundan, Polki, Diamond, and Studded Jewellery, has reported its Audited financial results for Q4 & FY26.

Key Financial Highlights 

Key Financial Highlights – FY26

  • Total Income of ₹16,703 Lakhs, YoY growth of 34%
  • EBITDA of ₹4,924 Lakhs, YoY growth of 33%
  • EBITDA Margin of 29.48%
  • Net Profit of ₹3,439 Lakhs, YoY growth of 36%
  • Net Profit Margin of 20.59%, YoY growth of 29 BPS
  • EPS of ₹10.74, YoY growth of 36%

Key Financial Highlights – Q4 FY26

  • Total Income of ₹4,323 Lakhs
  • EBITDA of ₹1,256 Lakhs
  • EBITDA Margin of 29.04%
  • Net Profit of ₹874 Lakhs
  • Net Profit Margin of 20.22%
  • EPS of ₹2.79

Commenting on the performance, Mr. Nitin Gilara, Chairman & Managing Director of Advit Jewels Limited, said: “FY26 has been a landmark year for Advit Jewels as we delivered robust financial performance while achieving a significant milestone with the successful listing of our equity shares on the NSE and BSE on July 01, 2026. This marks the beginning of a new chapter in our growth journey and reflects the trust placed in us by our investors and stakeholders.

During FY26, our Total Income increased by 33.68% to ₹16,702.56 Lakhs, while EBITDA grew by 32.52% to ₹4,923.80 Lakhs. Net Profit rose by 35.56% to ₹3,438.79 Lakhs, demonstrating the strength of our integrated business model, operational efficiency, and disciplined execution. We also maintained healthy profitability, with an EBITDA Margin of 29.48% and Net Profit Margin of 20.59%, despite a dynamic market environment.

Our focus on design-led innovation, superior craftsmanship, and customer-centric product offerings continues to strengthen our position in the premium jewellery segment. Backed by a legacy of over a century, we remain committed to expanding our market presence, enhancing our manufacturing capabilities, and creating sustainable long-term value for our shareholders. We are confident that the growing shift towards organised jewellery players and increasing demand for premium handcrafted jewellery will continue to support our long-term growth trajectory.”

About Advit Jewels Limited (RAMBHAJO)

Advit Jewels Limited (RAMBHAJO) is one of India’s leading manufacturers of traditional and contemporary handcrafted jewellery, specializing in Kundan, Polki, Diamond, and Studded Jewellery. With a family legacy dating back to 1921, the Company operates an integrated manufacturing facility in Jaipur, Rajasthan, and serves a wide network of jewellery retailers, wholesalers, and customers across India through its design-led and quality-focused approach.

The Company follows an integrated business model encompassing in-house design, manufacturing, stone setting, polishing, and quality control, enabling superior craftsmanship and timely delivery. Its diverse product portfolio includes bridal, antique, traditional, and customized jewellery, catering to evolving consumer preferences and market trends.

Backed by a strong manufacturing infrastructure with an installed capacity of 400 kg of gold jewellery annually, Advit Jewels combines skilled craftsmanship with modern manufacturing processes to deliver premium-quality jewellery. The Company continues to strengthen its presence across domestic markets while exploring opportunities to expand its footprint in international markets.

On July 01, 2026, Advit Jewels Limited achieved a significant milestone with the successful listing of its equity shares on the NSE and BSE, marking the beginning of a new growth chapter and reinforcing its commitment to creating long-term value for all stakeholders.

With a strong focus on innovation, product excellence, operational efficiency, and customer relationships, Advit Jewels is well-positioned to capitalize on the growing opportunities in India’s organized jewellery industry while continuing its legacy of craftsmanship and trust.

In FY26, Advit Jewels Limited reported Total Income of ₹ 16,702.56 Lakhs, EBITDA of ₹ 4,923.80 Lakhs, and a Net profit of ₹ 3,438.79 Lakhs.

Disclaimer: This article is for informational purposes only and does not constitute financial advice.

Truvora.ai Simplifies AI Tool Discovery with Its Browse by Category Experience
Truvora.ai Simplifies AI Tool Discovery with Its Browse by Category Experience
Sewa Grih Rin Rebrands as Sitaara Housing Finance Limited, Reinforcing Trust, Innovation and Responsible Lending
Sewa Grih Rin Rebrands as Sitaara Housing Finance Limited, Reinforcing Trust, Innovation and Responsible Lending
BNB and Solana Traders Watch Remittix After Raising USD 31M for Ecosystem Expansion
BNB and Solana Traders Watch Remittix After Raising USD 31M for Ecosystem Expansion